Eslicarbazepine Acetate
Products in Health Canada’s databases that list Eslicarbazepine Acetate as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 12
- 8 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 8
- Products in all
- 12
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| APO-ESLICARBAZEPINE (200 MG) | 02537931 | Marketed | Apotex Inc. | |
| APO-ESLICARBAZEPINE (400 MG) | 02537958 | Marketed | Apotex Inc. | |
| APO-ESLICARBAZEPINE (600 MG) | 02537966 | Marketed | Apotex Inc. | |
| APO-ESLICARBAZEPINE (800 MG) | 02537974 | Marketed | Apotex Inc. | |
| AURO-ESLICARBAZEPINE (200 MG) | 02527421 | Marketed | Auro Pharma Inc. | |
| AURO-ESLICARBAZEPINE (400 MG) | 02527448 | Marketed | Auro Pharma Inc. | |
| AURO-ESLICARBAZEPINE (600 MG) | 02527456 | Marketed | Auro Pharma Inc. | |
| AURO-ESLICARBAZEPINE (800 MG) | 02527464 | Marketed | Auro Pharma Inc. | |
| APTIOM (200 MG) | 02426862 | Cancelled Post Market | Sumitomo Pharma Canada, Inc. | |
| APTIOM (400 MG) | 02426870 | Cancelled Post Market | Sumitomo Pharma Canada, Inc. | |
| APTIOM (600 MG) | 02426889 | Cancelled Post Market | Sumitomo Pharma Canada, Inc. | |
| APTIOM (800 MG) | 02426897 | Cancelled Post Market | Sumitomo Pharma Canada, Inc. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- AURO-ESLICARBAZEPINEMay 7, 2025 · NOC 35312
- APO-ESLICARBAZEPINEFebruary 13, 2025 · NOC 34833
- APTIOMJanuary 25, 2024 · NOC 32597
- APTIOMJanuary 24, 2019 · NOC 21788
- APTIOMSeptember 12, 2018 · NOC 21307
- APTIOMJune 25, 2018 · NOC 21011
- APTIOMFebruary 2, 2018 · NOC 20458
- APTIOM (ESLICARBAZEPINE ACETATE)July 8, 2014 · NOC 15782